|
ANIP | Ani Pharmaceuticals Inc |
|
|
ANIP | Ani Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.22 |
| Leverage | 65.63% |
| Market Cap | $ 2.1B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -10.1m |
| Margin | -1.36% |
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.